Approval for modifications to the selox sr pacing lead family to change the steroid dosage, maximum lead body diameter, and ring electrode base material, as well as other minor changes.  The device, as modified, will be marketed under the trade name setrox s steroid-eluting active-fixation endocardial pacing lead and is indicated for permanent pacing and sensing.